The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 20,415 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 126,234 | 900,000 | SH | OTR | 900,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 16,480 | 2,094,000 | SH | OTR | 2,094,000 | 0 | 0 | ||
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 28,890 | 4,500,000 | SH | OTR | 4,500,000 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 55,200 | 1,200,000 | SH | OTR | 1,200,000 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | CALL | 29664W905 | 4,600 | 100,000 | SH | Call | OTR | 100,000 | 0 | 0 | |
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 28,735 | 700,000 | SH | OTR | 700,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 16,411 | 1,150,000 | SH | OTR | 1,150,000 | 0 | 0 | ||
| INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 60,474 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 3,950 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
| KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 8,162 | 290,577 | SH | OTR | 290,577 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 11,861 | 844,789 | SH | OTR | 844,789 | 0 | 0 | ||
| MATINAS BIOPHARMA HLDGS INC | COM | 576810105 | 3,358 | 5,642,858 | SH | OTR | 5,642,858 | 0 | 0 | ||
| MEDICINES CO | COM | 584688105 | 4,440 | 232,000 | SH | OTR | 232,000 | 0 | 0 | ||
| MEI PHARMA INC | COM NEW | 55279B202 | 7,691 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 66,411 | 1,565,560 | SH | OTR | 1,565,560 | 0 | 0 | ||
| NOVUS THERAPEUTICS INC | COM | 67011N105 | 519 | 324,383 | SH | OTR | 324,383 | 0 | 0 | ||
| ODONATE THERAPEUTICS INC | COM | 676079106 | 41,941 | 2,978,762 | SH | OTR | 2,978,762 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 73,960 | 2,155,000 | SH | OTR | 2,155,000 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 2,805 | 50,000 | SH | OTR | 50,000 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 29,137 | 1,966,051 | SH | OTR | 1,966,051 | 0 | 0 | ||
| SOLID BIOSCIENCES INC | COM | 83422E105 | 93,754 | 3,498,272 | SH | OTR | 3,498,272 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 34,584 | 1,200,000 | SH | OTR | 1,200,000 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 69,366 | 1,650,000 | SH | OTR | 1,650,000 | 0 | 0 | ||